FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA OKs First Drug-eluting Stent for Pulmonary Artery Disease

[ Price : $8.95]

FDA approves Cook, Inc.s Zilver PTX drug-eluting peripheral stent, the first drug-eluting stent indicated to re-open the femoropop...

Phase 3 Study Shows Gileads Complera Non-Inferior to Atripla In HIV Patients

[ Price : $8.95]

Gilead Sciences says results of a Phase 3b study showed single tablet regimens of Complera as non-inferior to Atripla in treatment...

Guidance on Nucleic Acid Tests for Hepatitis B in Blood Donors

[ Price : $8.95]

Federal Register Notice: FDA releases a guidance on the use of nucleic acid tests to screen blood donors for hepatitis B virus.

Appeals Court Upholds Treximet Patent Infringement Ruling

[ Price : $8.95]

The Federal Circuit Appeals Court upholds a lower court ruling that three generic drug companies infringed Pozens Treximet patent....

Hamburg Hammered by Own Party on Drug Compounding

[ Price : $8.95]

FDA commissioner Margaret Hamburg takes stiff criticism from her own party''s senators during a hearing on the drug compounding di...

Stakeholders Back, Oppose Proposed UDI Exemptions

[ Price : $8.95]

Stakeholders differ on whether FDA should exempt some devices from UDI requirements.

FDA Posts Latest Drug Safety Evaluation Summaries

[ Price : $8.95]

FDA posts summaries of 37 drug safety evaluations opened during the first half of 2012.

OTC Bronchodilator Labeling Guidance Out

[ Price : $8.95]

FDA publishes a question-and-answer guidance to help small businesses understand and comply with labeling requirements for broncho...

AMA Wants to End Pay-for-Delay

[ Price : $8.95]

The American Medical Association calls for an end to pay-for-delay agreements that can slow the marketing of generic drugs.

FDA Clears Vital Images 3-D Medical Viewer

[ Price : $8.95]

FDA clears a Vital Images 510(k) for three-dimensional viewing and computer tablet viewing through its universal viewer VitreaView...